TY - JOUR
T1 - From Free Binding Energy Calculations of SARS-CoV-2— Receptor Interactions to Cellular Immune Responses
AU - Glocker, Michael O.
AU - Opuni, Kwabena F.M.
AU - Thiesen, Hans Juergen
N1 - Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2022/2
Y1 - 2022/2
N2 - Our study focuses on free energy calculations of SARS-CoV-2 spike protein receptor binding motives (RBMs) from wild type and variants of concern (VOCs), with emphasis on SARS-CoV-2 Omicron. Our computational analysis underlines the occurrence of positive selection processes that specify Omicron host adaption and bring changes on the molecular level into context with clinically relevant observations. Our free energy calculation studies regarding the interaction of Omicron´s RBM with human angiotensin converting enzyme 2 (hACE2) indicate weaker binding to the receptor than Alpha´s or Delta´s RBMs. Upon weaker binding, fewer viruses are predicted to be generated in time per infected cell, resulting in a delayed induction of danger signals as a trade-off. Along with delayed immunogenicity and pathogenicity, more viruses may be produced in the upper respiratory tract, explaining enhanced transmissibility. Since in interdependence on the human leukocyte antigen type (HLA type), more SARS-CoV-2 Omicron viruses are assumed to be required to initiate inflammatory immune responses, and because of pre-existing partial immunity through previous infections and/or vaccinations, which mostly guard the lower respiratory tract, overall disease severity is expected to be reduced.
AB - Our study focuses on free energy calculations of SARS-CoV-2 spike protein receptor binding motives (RBMs) from wild type and variants of concern (VOCs), with emphasis on SARS-CoV-2 Omicron. Our computational analysis underlines the occurrence of positive selection processes that specify Omicron host adaption and bring changes on the molecular level into context with clinically relevant observations. Our free energy calculation studies regarding the interaction of Omicron´s RBM with human angiotensin converting enzyme 2 (hACE2) indicate weaker binding to the receptor than Alpha´s or Delta´s RBMs. Upon weaker binding, fewer viruses are predicted to be generated in time per infected cell, resulting in a delayed induction of danger signals as a trade-off. Along with delayed immunogenicity and pathogenicity, more viruses may be produced in the upper respiratory tract, explaining enhanced transmissibility. Since in interdependence on the human leukocyte antigen type (HLA type), more SARS-CoV-2 Omicron viruses are assumed to be required to initiate inflammatory immune responses, and because of pre-existing partial immunity through previous infections and/or vaccinations, which mostly guard the lower respiratory tract, overall disease severity is expected to be reduced.
KW - Computational biology
KW - Disease severity
KW - Receptor binding domain
KW - Receptor interaction
KW - SARS-CoV-2 Omicron
KW - Spike protein
KW - Transmissibility
UR - http://www.scopus.com/inward/record.url?scp=85124137591&partnerID=8YFLogxK
U2 - 10.3390/medicina58020226
DO - 10.3390/medicina58020226
M3 - Article
C2 - 35208550
AN - SCOPUS:85124137591
SN - 1010-660X
VL - 58
JO - Medicina (Lithuania)
JF - Medicina (Lithuania)
IS - 2
M1 - 226
ER -